Jump to ContentJump to Main Navigation
Show Summary Details

Hormone Molecular Biology and Clinical Investigation

Editor-in-Chief: Chetrite, Gérard S.

Editorial Board: Alexis, Michael N. / Baniahmad, Aria / Beato, Miguel / Bouillon, Roger / Brodie, Angela / Carruba, Giuseppe / Chen, Shiuan / Cidlowski, John A. / Clarke, Robert / Coelingh Bennink, Herjan J.T. / Darbre, Philippa D. / Drouin, Jacques / Dufau, Maria L. / Edwards, Dean P. / Falany, Charles N. / Fernandez-Perez, Leandro / Ferroud, Clotilde / Feve, Bruno / Flores-Morales, Amilcar / Foster, Michelle T. / Garcia-Segura, Luis M. / Gastaldelli, Amalia / Gee, Julia M.W. / Genazzani, Andrea R. / Greene, Geoffrey L. / Groner, Bernd / Hampl, Richard / Hilakivi-Clarke, Leena / Hubalek, Michael / Iwase, Hirotaka / Jordan, V. Craig / Klocker, Helmut / Kloet, Ronald / Labrie, Fernand / Mendelson, Carole R. / Mück, Alfred O. / Nicola, Alejandro F. / O'Malley, Bert W. / Raynaud, Jean-Pierre / Ruan, Xiangyan / Russo, Jose / Saad, Farid / Sanchez, Edwin R. / Schally, Andrew V. / Schillaci, Roxana / Schindler, Adolf E. / Söderqvist, Gunnar / Speirs, Valerie / Stanczyk, Frank Z. / Starka, Luboslav / Sutter, Thomas R. / Tresguerres, Jesús A. / Wahli, Walter / Wildt, Ludwig / Yang, Kaiping / Yu, Qi

CiteScore 2018: 2.43

SCImago Journal Rank (SJR) 2018: 0.947
Source Normalized Impact per Paper (SNIP) 2018: 0.837

    99,00 € / $149.00 / £80.00*

    See all formats and pricing
    More options …
    Select Volume and Issue



    Your benefits
    • Most recent research on urgent health issues related to hormones
    • Thorough selection of top articles within particular fields
    • Internationally recognized editorial board boosting the prestige of articles
    • Quick access to issues thanks to ahead of print publishing

    Aims and Scope

    Hormone Molecular Biology and Clinical Investigation (HMBCI) is dedicated to the provision of basic data on molecular aspects of hormones in physiology and pathophysiology. The journal covers the treatment of major diseases, such as endocrine cancers (breast, prostate, endometrium, ovary), renal and lymphoid carcinoma, hypertension, cardiovascular systems, osteoporosis, hormone deficiency in menopause and andropause, obesity, diabetes, brain and related diseases, metabolic syndrome, sexual dysfunction, fetal and pregnancy diseases, as well as the treatment of dysfunctions and deficiencies. HMBCI covers new data on the different steps and factors involved in the mechanism of hormone action. It will equally examine the relation of hormones with the immune system and its environment, as well as new developments in hormone measurements.

    HMBCI is a blind peer reviewed journal and publishes in English: Original articles, Reviews, Mini Reviews, Short Communications, Case Reports, Letters to the Editor and Opinion papers. Ahead-of-print publishing ensures faster processing of fully proof-read, DOI-citable articles.

    • The superfamily of receptors of the different hormones (steroids, polypeptides and related hormones), and co-regulators (activators and repressors);
    • Hormones related to the function of growth factors, oncogenes, and cytokines, in normal and neoplastic tissues;
    • Enzymes and anti-enzymes involved in the formation and disposition of various hormones in connection with the diseases stated above;
    • Hormone signaling and response to hormone therapy;
    • Mechanism of cancer cell proliferation under endocrine therapy;
    • Resistance to hormone therapy and its mechanism;
    • Hormones and the brain and other neuroendocrine organs;
    • Hormone replacement therapy;
    • Pre-clinical studies to test new molecules in isolated models and in human trials;
    • Hormones and the immune system;
    • Hormones and the environment;
    • Initiation and evolution of diseases related to the mechanism of action of hormones;
    • Therapeutic effect of hormones with regard to the method of administration.

    Article formats

    Original articles, Reviews, Mini Reviews, Short Communications, Case Reports, Letters to the Editor and Opinion papers

    Information on Submission Process


    Type of Publication:

    Researchers and practitioners interested in the topic of HMBCI

    Submission of Manuscripts

    Submission of Manuscripts

    Please submit your papers directly to our online submission system

    Instructions for Authors


    You can easily submit your manuscript online. Simply go to http://mc.manuscriptcentral.com/hmbci and you will be guided through the whole peer reviewing and submission process.

    Your benefits of publishing with us
    • Easy-to-use online submission, peer review, and publication system
    • Editors will do their best to make decisions on your submission as soon as possible
    • Blind peer review procedure
    • Every article easily discoverable because of Search Engine Optimization (SEO) and comprehensive abstracting and indexing services
    • Convenient citation tracking via e-mail alert
    • Secure archiving by De Gruyter and the independent archiving service Portico
    • Professional sales and marketing activities

    Submission process
    Submission of your paper via our submission management tool following the Instruction for Authors (you will be guided through every step of the submission process)

    Please note

    We look forward to receiving your manuscript!

    More ...

    Abstracting & Indexing

    Hormone Molecular Biology and Clinical Investigation is covered by the following services:

    • Baidu Scholar
    • Case
    • Chemical Abstracts Service (CAS) - CAplus
    • Chemical Abstracts Service (CAS) - SciFinder
    • CNKI Scholar (China National Knowledge Infrastructure)
    • CNPIEC - cnpLINKer
    • Dimensions
    • EBSCO (relevant databases)
    • EBSCO Discovery Service
    • Embase
    • Genamics JournalSeek
    • Google Scholar
    • Japan Science and Technology Agency (JST)
    • J-Gate
    • JournalGuide
    • JournalTOCs
    • KESLI-NDSL (Korean National Discovery for Science Leaders)
    • Medline
    • Meta
    • Microsoft Academic
    • MyScienceWork
    • Naviga (Softweco)
    • Norwegian Register for Scientific Journals, Series and Publishers
    • Primo Central (ExLibris)
    • ProQuest (relevant databases)
    • Publons
    • PubMed
    • QOAM (Quality Open Access Market)
    • ReadCube
    • Reaxys
    • SCImago (SJR)
    • SCOPUS
    • Semantic Scholar
    • Sherpa/RoMEO
    • Summon (ProQuest)
    • TDNet
    • Text Mining
    • Ulrich's Periodicals Directory/ulrichsweb
    • WanFang Data
    • Web of Science - Emerging Sources Citation Index
    • WorldCat (OCLC)

    Editorial Information

    Gérard S. Chetrite
    Faculty of Medecine
    Paris-Sud University
    E-mail: gerard.chetrite@u-psud.fr

    Associate Editors

    • Bruno Feve, Centre de Recherche Saint-Antoine, Faculté de Médecine Pierre et Marie Curie, Paris/France
    • Michelle T. Foster, Department of Food Science and Human Nutrition, Colorado State University, Fort Collins/USA
    • Bernd Groner, Georg-Speyer Haus, Frankfurt am Main/Germany
    • Michael Hubalek, Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck/Austria
    • Farid Saad, Global Medical Affairs Andrology, Bayer Pharma AG, Berlin/Germany
    • Andrew V. Schally, Departments of Pathology and Medicine, University of Miami, Miller School of Medicine, Miami/USA

    Corresponding Editors

    • Michael N. Alexis, Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation, Athens/Greece
    • Aria Baniahmad, Institute of Human Genetics, Jena University Hospital, Jena/Germany
    • Miguel Beato, Centre for Genomic Regulation, The Barcelona Institute for Science and Technology, Barcelona/Spain
    • Roger Bouillon, Clinical and Experimental Endocrinology, KU Leuven, Leuven/Belgium
    • Angela Brodie, Department of Pharmacology, University of Maryland, Baltimore/USA
    • Giuseppe Carruba, Division of Research and Internationalization, ARNAS Civico, Palermo/Italy
    • Shiuan Chen, Department of Cancer Biology, Beckman Research Institute of the City of Hope, Duarte/USA
    • John A. Cidlowski, Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, Research Triangle Park, Durham/USA
    • Robert Clarke, Department of Oncology and Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington DC/USA
    • Herjan J.T. Coelingh Bennink, Pantarhei Bioscience, Zeist/Netherlands
    • Philippa D. Darbre, School of Biological Sciences, University of Reading, Reading/UK
    • Ronald de Kloet, Leiden Academic Centre for Drug Research, Leiden University, Leiden/Netherlands
    • Alejandro F. De Nicola, Department of Human Biochemistry, Faculty of Medicine, University of Buenos Aires, Buenos Aires/Argentina
    • Jacques Drouin, Laboratory of Molecular Genetics, Institute for Clinical Research, Montréal/Canada
    • Maria L. Dufau, Section on Molecular Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda/USA
    • Dean P. Edwards, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston/USA
    • Charles N. Falany, Department of Pharmacology and Toxicology, University of Alabama at Birmingham School of Medicine, Birmingham/USA
    • Leandro Fernández-Pérez, Institute for Research in Biomedicine and Health, University of Las Palmas de Gran Canaria, Las Palmas de G.C./Spain
    • Clotilde Ferroud, French National Conservatory of Arts and Crafts, CNAM, Paris/France
    • Amilcar Flores-Morales, Faculty of Health Sciences, University of Copenhagen, Copenhagen/Denmark
    • Luis M. García-Segura, Cajal Institute, Spanish National Research Council, Madrid/Spain
    • Amalia Gastaldelli, Institute of Clinical Physiology, CNR, Pisa/Italy
    • Julia M.W. Gee, School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Cardiff/UK
    • Andrea R. Genazzani, Department of Gynaecology and Obstetrics, European Society of Gynecology, University of Pisa, Pisa/Italy
    • Geoffrey L. Greene, The Ben May Department for Cancer Research, The University of Chicago, Chicago/USA
    • Richard Hampl, Department of Steroids and Proteofactors, Institute of Endocrinology, Prague/Czech Republic
    • Leena Hilakivi-Clarke, Georgetown Lombardi Comprehensive Cancer Center, Washington/USA
    • Hirotaka Iwase, Department of Breast and Endocrine Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto/Japan
    • V. Craig Jordan, Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston/USA
    • Helmut Klocker, Department of Urology, Medical University of Innsbruck, Innsbruck/Austria
    • Fernand Labrie, Endoceutics Inc., Quebec City/Canada
    • Carole R. Mendelson, Departments of Biochemistry and Obstetrics and Gynecology, North Texas March of Dimes Birth Defects Center, University of Texas Southwestern Medical Center, Dallas/USA
    • Alfred O. Mück, Department of Endocrinology and Menopause, University Hospital Tübingen, Tübingen/Germany
    • Bert W. O'Malley, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston/USA
    • Jean-Pierre Raynaud, University Pierre & Marie Curie, Paris/France
    • Xiangyan Ruan, Department of Gynecological Endocrinology, Beijing Obstetrics & Gynecology Hospital, Capital Medical University, Beijing/China
    • José Russo, The Irma H. Russo MD Breast Cancer Research Laboratory, Fox Chase Cancer Center, Philadelphia/USA
    • Edwin R. Sanchez, Department of Physiology & Pharmacology, University of Toledo College of Medicine, Toledo/USA
    • Roxana Schillaci, Experimental Biology and Medicine, University of Buenos Aires, Buenos Aires/Argentina
    • Adolf E. Schindler, Institute for Medical Research and Education, University hospital Essen, Essen/Germany
    • Gunnar Söderqvist, Department of Women's and Children's Health, Karolinska Institute, Karolinska University Hospital, Stockholm/Sweden
    • Valerie Speirs, Leeds Institute of Cancer and Pathology, University of Leeds, Leeds/UK
    • Frank Z. Stanczyk, Departments of Obstetrics and Gynecology, and Preventive Medicine, University of Southern California Keck School of Medicine, Los Angeles/USA
    • Luboslav Stárka, Department of Steroids Hormones and Proteohormones, Institute of Endocrinology, Prague/Czech Republic
    • Thomas R. Sutter, Department of Biological Sciences, University of Memphis, Memphis/USA
    • Abdulmaged Traish, Department of Biochemistry and Department of Urology, Boston University School of Medicine, Boston/USA
    • Jesus A. Tresguerres, Department of Physiology, School of Medicine, Complutense University of Madrid, Madrid/Spain
    • Walter Wahli, Center for Integrative Genomics, University of Lausanne, Lausanne/Switzerland
    • Ludwig Wildt, Department of Gynecological Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Innsbruck/Austria
    • Kaiping Yang, Departments of Obstetrics and Gynaecology and Physiology and Pharmacology, Children's Health Research Institute and Lawson Health Research Institute, Western University, London/Canada
    • Qi Yu, Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Beijing/China

    Managing Editor
    Alexandra Hinz
    Walter de Gruyter GmbH
    Genthiner Straße 13
    10785 Berlin, Germany
    T + 49 (0)30-260 05-358
    E-mail: HMBCI.Editorial@degruyter.com

    Comments (0)

    Please log in or register to comment.
    Log in